How does the FDA not require dual sourcing and at least 50% domestic production as requirements is beyond me.
we really need drugs to move more rapidly through the cycle of being novel and experimental to patent-unencumbered commodities, and open up competition in hospitals (i.e., don't let them charge $400 a pop for their monopoly tylenol). in fact, we need a more vigilant and active FTC and a high-functioning commerce department to stamp out monopoly behavior and encouurage competition across the board.
i'm also ok with setting up tariffs, with mandatory sunset provisions, to allow time for international price equalization of all sorts of outsourced industries. global markets aren't yet competitive and equitable (for instance, pricing in pollution externalities on manufacturing and shipping), and we won't get a structural move to re-industrialization without it.
Dual sourcing would largely offset the protections of patents in the system... of course there should also be patent reform, but at least with a dual sourcing requirement it would largely allow for self-correcting.